Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology.

Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology.
复制标题

DOI:
10.1002/cncr.24134
复制
发表时间:
2009-03-15
期刊:
影响因子:
6.2
通讯作者:
Weinfurt, Kevin P.
Weinfurt, Kevin P.
中科院分区:
医学1区
文献类型:
--
作者:
Jeffery, Diana D.;Tzeng, Janice P.;Keefe, Francis J.;Porter, Laura S.;Hahn, Elizabeth A.;Flynn, Kathryn E.;Reeve, Bryce B.;Weinfurt, Kevin P.

文献摘要

参考文献

被引文献

相似文献

本报告描述了癌症患者报告结果测量信息系统(PROMIS)性功能领域小组(CaPS-SF)的初步活动,这是美国国立卫生研究院(NIH)路线图倡议的一部分,旨在开发简短的问卷调查或个人定制的生活质量领域评估。我们的文献回顾性功能测量用于癌症人群,并在这些措施中发现的域的描述,是提出。采用共识驱动的方法,对1991-2007年发表的文章进行了电子书目检索,得到486篇文章进行深入审查。总共有257篇文章报道了对诊断为癌症的个体进行心理测量评估性功能测量的管理。除了加州大学洛杉矶分校前列腺癌指数、国际勃起功能指数和女性性功能指数外,这31项确定的指标尚未在癌症人群中进行广泛测试。大多数测量是多维度的,包括与性反应周期和一般性满意度相关的领域。我们的综述支持在肿瘤学环境中使用一种灵活的、心理测量学上可靠的性功能测量方法的需求,并强烈支持开发promise - sf仪器。在promise - sf公开可用后,癌症临床医生和研究人员将有另一种方法来评估患者报告的性功能结果,而不是通过我们的综述确定的一些遗留措施。
This report describes initial activities of the Cancer Patient-Reported Outcomes Measurement Information System (PROMIS) Sexual Function domain group (CaPS-SF), part of the National Institutes of Health (NIH) Roadmap Initiative to develop brief questionnaires or individually-tailored assessments of quality of life domains. Our literature review of sexual function measures used in cancer populations, and descriptions of domains found in those measures, is presented. Using a consensus-driven approach, an electronic bibliographic search was conducted for articles published 1991-2007, yielding 486 articles for in-depth review. A total of 257 articles reported the administration of a psychometrically evaluated sexual function measure to individuals diagnosed with cancer. Apart from the UCLA Prostate Cancer Index, the International Index of Erectile Function, and the Female Sexual Function Index, the 31 identified measures have not been widely tested in cancer populations. Most measures were multidimensional and included domains related to the sexual response cycle and to general sexual satisfaction. Our review supports the need for a flexible, psychometrically robust measure of sexual function for use in oncology settings and strongly justifies the development of the PROMIS-SF instrument. After PROMIS-SF is publicly available, cancer clinicians and researchers will have another measure to assess patient-reported sexual function outcomes in addition to the few legacy measures identified through our review.
DOI: 10.1111/j.1464-410x.2008.07515.x
发表时间: 2008-05-01
期刊: BJU INTERNATIONAL
影响因子: 4.5
作者:
Bannowsky, Andreas;Schulze, Heiko;Juenemann, Kalus-Peter
通讯作者: Juenemann, Kalus-Peter
DOI: 10.1111/j.1743-6109.2008.00893.x
发表时间: 2008-08-01
影响因子: 3.5
作者:
Alder, Judith;Zanetti, Rosanna;Bitzer, Johannes
通讯作者: Bitzer, Johannes
DOI: 10.1016/j.gyobfe.2004.06.004
发表时间: 2004-07-01
期刊: Gynecologie, obstetrique & fertilite
影响因子: --
作者:
Coeffin-Driol, C;Giami, A
通讯作者: Giami, A
DOI: 10.1080/00926230490465091
发表时间: 2004-10-01
影响因子: 2.5
作者:
Çayan, S;Bozlu, M;Akbay, E
通讯作者: Akbay, E
DOI: 10.1111/j.1464-410x.2007.07016.x
发表时间: 2007-08-01
期刊: BJU INTERNATIONAL
影响因子: 4.5
作者:
Cesaretti, Jamie A.;Kao, Johnny;Stock, Richard G.
通讯作者: Stock, Richard G.